Gland Pharma (BOM:543245) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gland Pharma's Free Cash Flow for the three months ended in Sep. 2024 was ₹0 Mil. Gland Pharma's Revenue for the three months ended in Sep. 2024 was ₹14,058 Mil. Therefore, Gland Pharma's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Gland Pharma's current FCF Yield % is 2.16%.

The historical rank and industry rank for Gland Pharma's FCF Margin % or its related term are showing as below:

BOM:543245' s FCF Margin % Range Over the Past 10 Years
Min: 2.48 Med: 7.4 Max: 19.69
Current: 10.2

During the past 7 years, the highest FCF Margin % of Gland Pharma was 19.69%. The lowest was 2.48%. And the median was 7.40%.

BOM:543245's FCF Margin % is ranked better than
73.58% of 988 companies
in the Drug Manufacturers industry
Industry Median: 1.04 vs BOM:543245: 10.20

Gland Pharma FCF Margin % Historical Data

The historical data trend for Gland Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma FCF Margin % Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

19.69

10.99

6.13

3.92

10.61

Gland Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gland Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Gland Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gland Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gland Pharma's FCF Margin % falls into.

Gland Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gland Pharma's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	5985.41	/	56417.32
	=	10.61 %

Gland Pharma's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0	/	14058.33
	=	0.00 %

Gland Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Gland Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (BOM:543245) » Definitions » FCF Margin %

Traded in Other Exchanges

GLAND:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. The group is also involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma Headlines

No Headlines